When a doctor has to hire 3 people just to handle insurance billing, we can decrease health care costs by going to a single payer system. if we can eliminate pharmacy benefit managers by going to single payer we will lower health care costs. #SCHD18
Dr Anderson: pharma spends more on marketing than on R&D. Get rid of direct to consumer advertising to lower costs. #SCHD18
Dr Michael Seiden says that at some point the US is going to have to ration care. @double_whammied asks does he mean rationing care for patients or rationing of profiteering by companies. Yes Diane!!! #SCHD18
Move to delivering care in the hospital vs in office is increasing costs. #SCHD18
Dr Anderson get huge applause for this line: "the electronic medical record is built for billing and not patient care" #SCHD18
We all want the new, shiny, sexy targeted therapies, but there is still a place for effective, lower cost chemo. Dr Brian Koffman, FO doc and CLL patient. #SCHD18
Dr Lyman: as long as drug prices are based on what the market will bear, we will have problems. We need value based pricing. We need regulations. We all need to vote #SCHD18
Dr Michael Seiden: as we speed up drug development and prices increase, we will worsen disparities.
#SCHD18
.@JFreemanDaily ?: how to get advocates involved early? Advocates have to knock on doors and rattle cages at institutions and pharma to get a seat at the table. Ask your onc for introductions. #SCHD18
Dr Koffman: smaller, adaptive trials will speed discovery. Open up eligibility criteria to get real world data. Get the lawyers out! #SCHD18
Dr Lyman: we generate a lot of data but don't have a coordinated national mechanism or platform to collate all this data. #SCHD18
Dr Brian Kofffman: we need to involve patients from day one. Patients care about OS and PFS. And ask the patients what they want!! #SCHD18
Dr Gary Lyman: @FDAOncology should consider drug prices (which will require congressional direction/approval). CMS needs to be able to negotiate prices. More competition to decrease prices . #SCHD18
Dr Anderson: we shouldn't approve drugs with minimal benefit. Smaller, biomarkers driven trials will cost less, be faster, and lead to more effective treatments. #SCHD18
Drug costs for patients have gone up 600% over the last 10 years. How do we reduce the cost of care? #SCHD18
.@double_whammied introducing Dr Brian Koffman, who also straddles the line between doctor and patient (he has CLL) #SCHD18
Moderators for next #SCHD18 debate include @double_whammied, here conferring with conference organizer @binayshah
Dr Timothy Erickson: in order to reach refugees/immigrants/communities affected by disparities, must use advocates who are of and understand the particular culture #SCHD18
Dr Scott Ramsey of @fredhutch HICOR as a possible model for disrupting cancer care, improving quality & access while decreasing costs #SCHD18
This advocate, who runs a nonprofit that helps with non-medical expenses , points out that the people they help are middle class, with insurance, that are unable to pay for cancer care AND personal expenses. #financialtoxicity #SCHD18
Social media can also be a way for researchers to reach out to patients about clinical trials @JFreemanDaily #bcsm #lcsm #SCHD18
.@JFreemanDaily speaking to the panel about the power of social media. @ros1cancer @METUPorg #bcsm #lcsm #SCHD18
.@mbcalliance maybe taking a page from @LLSusa and making #MBCConnect a supported navigation tool would be more useful for us. #SCHD18
Patient advocacy organizations need to make statements about patient-centered reforms to make drugs and treatments affordable, and to push for competition to lower prices #SCHD18
.@DrGwenNichols of @LLSusa speaking on the role of advocacy organizations in addressing disparities #SCHD18
Community oncology outreach is key for people like me who don't live in a big city with a major NCI-designated cancer center. #SCHD18
